Technology-supported Interventions for Prolonged Grief Disorder (PGD)

Launched by UNIVERSITAT JAUME I · Apr 16, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring new ways to help people who are experiencing Prolonged Grief Disorder (PGD), which is a condition where individuals have intense and lasting feelings of sadness after losing a loved one. The study is testing two different online treatment approaches: one combines online exercises with video sessions with a therapist (called BF-GROw), and the other is a self-guided online program that uses real-time check-ins and support (called iGROw). The goal is to see if either of these methods can better help people cope with their grief compared to those who are not receiving any treatment at the moment.

To participate in the trial, individuals must be at least 18 years old, be diagnosed with PGD, and be able to read and understand Spanish. They also need access to a computer and the internet, including an email address and smartphone. However, people with certain severe mental health issues, those at risk of suicide, or those receiving other psychological treatments during the study will not be eligible. Participants can expect to engage with the online program and possibly have video sessions with a therapist, all while contributing to important research that could improve how grief is treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being at least 18 years old.
• • Meeting diagnostic criteria for Prolonged Grieft Disorder based on the International Classification of Diseases 11 edition (ICD-11).
• • Sign an informed consent.
• • Ability to understand and read Spanish.
• • Ability to use a computer.
• • Having an e-mail address.
• • Having an internet connection and Access to a Smartphone.
• Exclusion Criteria:
• • Presence of high risk of suicide.
• • Presence of axis I severe mental disorder: substance abuse or dependence, psychotic disorder, dementia, bipolar disorder; severe personality disorder or medical illness whose severity or characteristics prevent treatment.
• • Receiving other psychological treatment during the study.
• • An increase and/or change in the medication during the study period, in the case of receiving pharmacological treatment.